Mandate

Vinge advises Active Biotech on rights offering

August 05, 2022

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 million.

Vinge advises Active Biotech. Vinge’s team primarily consists of Christian Lindhé, Erik Sjöman, Astrid Isberg and Johanne Örnfeldt Svensson.

Related

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026